King III, MD Background. Restenosis after percutaneous transluminal coronary angioplasty is the major limitation of the long-term success of this procedure. The process of restenosis is similar to an accelerated form of atherosclerosis. Thus, therapeutic interventions that limit the progression and initiation of atherosclerosis may be beneficial in the treatment of restenosis. One such intervention is the antioxidant drug probucol, which has demonstrated benefit in animal models of atherosclerosis.
R estenosis after percutaneous transluminal coronary angioplasty (PTCA) is the major limitation of the long-term success of this procedure.' Despite numerous trials of pharmacological interventions, including antiplatelet agents, heparin, coronary vasodilators, and fish oils, the frequency of restenosis has not diminished since the inception of PTCA 15 years ago. [2] [3] [4] [5] Although new mechanical interventions including stents and atherectomy recently have been reported to reduce the incidence of restenosis, achieving a larger lumen rather than reducing neointimal growth appears to be the mechanism.6-8 The process of restenosis is complex and not fully understood. After vascular injury from balloon angioplasty, a series of interactions between blood elements and the vessel wall promote smooth muscle cell migration and proliferation within the vessel intima.9,10 This response to vascular injury resembles atherosclerosis, and restenosis has been considered an accelerated version of this process." An evolving concept in the pathogenesis of atherosclerosis is the role of oxidative stress. Oxidized lowdensity lipoproteins (LDLs) contribute to foam cell formation and have been demonstrated within the atherosclerotic plaque.'2 The importance of oxidative stress in the initiation of atherosclerosis has been demonstrated in animal models. One of the most dramatic examples was the ability of the antioxidant drug probucol to limit atherogenesis in the Watanabe heritable hyperlipidemic rabbit.'3 Additional support for the role of oxidative stress in vascular disease was the ability of various antioxidants to limit the extent of reperfusion injury after thrombolysis in experimental models of acute myocardial infarction.'4"15 Increased generation of active oxygen species (H202, 02-, OH-) by inflammatory cells and vascular wall cells (smooth muscle and endothelial cells) in response to oxidative stress may potentiate vascular lesion formation and represents a common link between atherosclerosis and restenosis. Recent findings indicate that active oxygen species may act as vascular smooth muscle cell mitogens and thus play a role in restenosis. 16 Therefore, we studied the ability of probucol, a well-characterized antioxidant drug, to reduce neointimal formation in a porcine model of restenosis. Probucol was chosen because of the extensive knowledge of its antioxidant properties as well as its use in previous animal studies. 17 The swine model offers specific advantages over other animal models for the study of restenosis because of the similarities with the human coronary circulation, the spontaneous development of atherosclerosis, and the response to vascular injury. [18] [19] [20] We have developed and characterized a balloon injury model of coronary restenosis in normolipemic swine. Histological analysis reveals intimal smooth muscle cell proliferation similar to the hyperplasia seen in human restenosis. 21 The purpose of the present study was to determine if the antioxidant drug probucol could reduce the extent of neointimal formation after balloon injury in swine coronary arteries.
Methods

Animals
We studied 26 juvenile domestic female swine weighing between 18 and 30 kg. The animals were randomized into three study groups. Group 1 (control) consisted of nine untreated animals. Group 2 (low-dose probucol) included nine swine that received probucol 500 mg twice a day beginning 2 days before balloon injury and continuing throughout the 2-week study period. Group 3 (high-dose probucol) consisted of eight swine that received high-dose probucol 1000 mg twice a day also beginning 2 days before balloon injury and being administered throughout the study period. The drug was given by tablets crushed to powder form and mixed with corn syrup. Control and probucol-treated animals received daily 325 mg aspirin mixed with corn syrup to reduce the incidence of acute thrombosis after balloon injury. The animals were observed to ensure the medication was taken. All animals were fed a normolipemic diet.
All experimentation and animal care in this study conformed to the National Institutes of Health and American Heart Association guidelines for the care and use of animals. The study was approved by the Emory Animal Care and Use Committee.
Lipid Measurements
In a subset of seven animals (two control, two lowdose probucol, and three high-dose probucol), plasma cholesterol and lipoproteins were determined at the time of initial balloon injury and at the time the swine were killed 14 days later.
Experimental Protocol
The model of overstretch balloon injury has been described previously. The animals were sedated with a combination of ketamine (25 mg/kg; Aveco Co, Inc, Fort Dodge, Iowa), acepromazine (1.1 mg/kg; Aveco Co, Inc), and atropine (0.6 mg/kg) administered in combination by intramuscular injection. An intravenous line was established, and each animal received intravenous Brevitol (10 mg/kg or to effect; Eli Lilly, Indianapolis, Ind) to facilitate supine positioning and endotracheal intubation with a cuffed endotracheal tube. Each animal was ventilated with oxygen (2 L/min), nitrous oxide (2 L/min), and isoflurane 1% (2 L/min; Anaquest, Madison, Wis) using a Harvard respirator (South Natick, Mass). Adequate anesthesia was confirmed by the absence of a limb withdrawal reflex. The ECG and intra-arterial blood pressure were monitored throughout the procedure.
After placement of an 8F introducer sheath in the right femoral artery, each animal received a single dose of heparin (200 U/kg) and bretylium tosylate (2.5 mg/kg; Du Pont, Wilmington, Del). Under fluoroscopic guidance, an 8F hockey stick guiding catheter was positioned in the left coronary ostium. After the intracoronary administration of nitroglycerin (200 ,ug), coronary angiography was performed in the 450 left anterior oblique (LAO) and 450 right anterior oblique (RAO) views and was recorded on cinefilm (Cinerex PFA, Belgium).
Coronary injury was achieved by deliberate stretch of the vessel wall with an oversized angioplasty balloon. Over a flexible 0.014-in. angioplasty wire, a 3.5-mm diameter, 20-mm-length polyethylene terephthalate balloon (USCI, Billerica, Mass) was positioned between the first and second diagonal branches of the left anterior descending artery. Three 30-second inflations were performed at 10 atm, and each inflation was separated by a 1-minute deflation period to allow for coronary perfusion. After the completion of the third inflation, the angioplasty balloon was withdrawn, and additional nitroglycerin (200 gg) was administered to limit coronary spasm. In a similar fashion, the guide wire and angioplasty balloon were positioned between the first and second marginal branch of the left circumflex artery (LCx), and the procedure was repeated. At the completion of the final inflation, the angioplasty equipment was removed, and intracoronary nitroglycerin (200 gg) was administered. Final coronary angiography was performed in identical LAO and RAO views to assess vessel patency and the extent of postinjury dilation. The guiding catheter and sheath were removed, and the cutdown was repaired. Nitroglycerin ointment (1 in.) was administered topically, and the animals were allowed to recover.
The animals underwent follow-up coronary angiography and were killed 14 days after the initial overstretch injury. Angiography was performed in similar 450 RAO and LAO views as per the initial study. Heparin (200 U/kg) was given before the animals were killed. A lethal dose of a sodium pentobarbitol (65 mg/kg) and ethyl alcohol (65 mg/kg) combination was administered, and the heart was rapidly excised through a left thoracotomy. The left main coronary artery was cannulated with a perfusion device, and the left coronary system was perfusion-fixed at 100 mm Hg with 10% buffered formalin for 15 minutes.
Tissue Analysis
The injured coronary segments of the LAD and LCx were located with the guidance of the coronary angiograms, then were dissected in block from the heart. Serial 4-mm sections were processed and embedded in paraffin. Cross-sections (4 ,m thick) were stained with hematoxylin-eosin, Verhoeff-van Gieson, and Masson's trichrome stains. Each specimen was examined by an experienced cardiovascular pathologist blinded to the treatment group. Each specimen was evaluated for the presence of intimal proliferation, luminal encroachment, medial dissection, and alteration of the internal and external elastic lamina. A grading system based on the criteria listed in Table 1 was applied to the most reactive segment. Sections were also evaluated for the presence of luminal and/or intramural thrombi, eccentricity of lesions, and presence of medial dissection. Each specimen was stained for smooth muscle cells (anti-a-actin antibody) and for macrophages (HAM-55 antibody). An assessment of the composition of the neointima was determined based on the standard and special stains.
Morphometric analysis was performed on the section of each artery with the largest neointimal lesion using a computerized IBM-based system (BIoscAN 2, Thomas Optical Measurement System, Inc, Columbus, Ga). The maximal intimal thickness was determined by a line between the lumen and outermost point of the neointima. Area measurements were obtained by tracing the lumen and neointima (defined by the borders of the internal elastic lamina, lumen, media, and external elastic lamina in those areas in which medial disruption had occurred). Data were expressed as the maximal intimal thickness (millimeters), the intimal area (square millimeters), and the residual lumen (luminal to intimal plus luminal ratio). The latter measurement reflected the change in vessel geometry after injury and repair. In the normal artery, the intimal area is trivial, and therefore the ratio approximates 1. As the extent of intimal proliferation increases, expressed as the area within the neointima, and the vessel lumen is altered, the ratio of the luminal area to intimal plus luminal area decreases. The morphometric measurements are illustrated in 
Angiographic Analysis
Angiographic analysis was performed on the cinefilms obtained during the baseline study (initial balloon injury) and follow-up study (when the animals were killed). The baseline study included measurements of the injury site before and after balloon dilatation as well as the balloon to artery ratio. The follow-up study included determination of the percent luminal narrowing at the injury site. Analysis was performed by handheld digital electronic calipers by an angiographer blinded to treatment groups. Measurements were corrected to absolute luminal diameters by use of the guiding catheter tip as an internal calibration standard.
Statistical Analysis
Data are expressed as mean±SEM. We compared morphometry data by a two-factor ANOVA (vessel and treatment). To compare group means after computation of the ANOVA, a contrast was set up and yielded F and P values. Baseline swine data and percent change in the angiographic luminal diameters were determined by a one-factor ANOVA (treatment groups). The percent change in lipid levels was determined by a one-factor repeated-measures ANOVA (treatment groups). The statistics were computed with the program SUPERANOVA from Abacus Concepts. A value of P<.05 was considered significant.
Results Group characteristics are listed in Table 2 . There were no significant differences in animal weight among the groups at the time of balloon injury. Two of the 26 swine died during the initial procedure. Both deaths were attributed to acute thrombosis of a ballooned coronary artery; one death occurred in the control group and the second in the low-dose probucol group. These two animals were excluded from the analysis. There were no postprocedural complications.
Plasma Lipids
In a subset of seven animals, plasma cholesterol and lipoproteins were determined at the time of injury (48 hours after first dose) and when the animals were killed 14 days later. The absolute change in lipid levels is illustrated in Fig 2. In the high-dose probucol group, a fall in total and LDL cholesterol of 16% and 11%, respectively, was evident during the treatment period. Additionally, probucol lowered high-density lipoproteins (HDL) by 21% in the high-dose treatment group. In the control and low-dose probucol group, a rise in total cholesterol, LDL, and HDL was noted during the 2-week interval. This increase in lipid levels over time is consistent with other studies performed by this laboratory.
Angiographic Analysis
Angiographic analysis was performed by digital calipers to determine the degree of vessel stretch before and after balloon injury, the balloon to artery ratio, and the luminal narrowing at the time of follow-up (when the animals were killed). As presented in Table 2 , the balloon to artery ratio was similar between groups: 1.36+0.13 (control group), 1.41±0.17 (low-dose probucol), and 1.43±0.19 (high-dose probucol). Similarly, the vessel stretch after balloon injury did not differ among groups with an average increase in vessel diameter after injury of 20±10% (control), 21±14% (low-dose probucol), and 23±16% (high-dose probucol). After oversize Effect of Probucol on lipid levels balloon injury, spasm occurred in 6 of the 48 vessels. These six vessels were excluded from the analysis of postinjury stretch. Consistent with previous findings in this model, no significant change was noted in the angiographic luminal diameter of the injured segment 2 weeks after overstretch injury.
Histopathological Analysis
To document coronary artery injury and characterize the neointima, histological analysis of all arterial segments was performed. As shown in Fig 3, there was rupture of the internal elastic lamina with neointimal growth replacing the disrupted media at 2 weeks after injury. The neointima consisted of smooth muscle cells, loose connective tissue, and proteoglycans, as identified by light microscopy. Staining for a-actin confirmed that smooth muscle cells were the dominant cell type in the neointima as demonstrated in Fig 4. Immunohistochemical staining with HAM-55 demonstrated rare macrophages in the neointima. Injury was documented in 43 of 48 vessels. The remaining five arteries had an intact internal elastic lamina and were deemed noninjured segments. These five arteries received a histopathological grade of 0. The lack of injury was presumed to be due to an error in sampling at the time of specimen preparation. These five segments were excluded from (Table 2) .
Morphometry
Morphometry was performed on the arterial segment with the largest neointimal lesion as identified by histopathological analysis. Several independent measurements of the vessel response to injury were performed. The maximal intimal thickness and the absolute intimal area should reflect the proliferative response at the site of vessel injury and thus serve as the best indicators of the ability of probucol to reduce neointimal mass after injury. The residual lumen (luminal to intimal plus luminal ratio) demonstrated the change in vessel geometry after injury and repair and may more closely parallel the clinical entity of restenosis.
To determine whether probucol altered the response to injury, the extent of neointimal formation was determined in each group. Animals receiving low-dose and high-dose probucol had less neointima than untreated animals, as shown by both the maximal intimal thickness (0.46+0.03 mm for the control, 0.44±0.03 mm for the low-dose probucol, and 0.37±0.03 mm for the high-dose probucol) and the absolute intimal area (0.87+0.08 mm2 for the control, 0.70+0.10 mm2 for the low-dose probucol, and 0.56±0.07 mm2 for the high-dose probucol) (see Fig 5) . Thus, probucol caused 20% and 36% reductions in intimal area in the low-dose and high-dose groups, respectively. This was paralleled by a 20% reduction in the maximal intimal thickness in the high-dose group. There was a significant overall treatment effect in the intimal area by the ANOVA (P=.025), which was highly significant in the subgroup analysis comparing control versus high-dose probucol (P=.007). The change in maximal intimal thickness was not significant when all data were analyzed simultaneously (P=.10), but a clear trend was observed in the high-dose probucol group. As illustrated in Fig 6, the residual lumen was larger in the low-dose and high-dose probucol groups (0.68+0.02, control; 0.72+0.04, low-dose probucol; and 0.80±0.02, high-dose probucol). The overall main effect of the residual lumen by the ANOVA was borderline (P=.06) but achieved significance in the high-dose probucol group by the subgroup analysis (P=.02). Table 3 compares the group means by vessel (LAD, LCx, and combined vessels) and treatment.
Discussion
The major finding of this study is that the antioxidant drug probucol reduced the extent of intimal proliferation after oversized balloon injury in a swine model of coronary restenosis. The effect of probucol was significant in reducing the neointimal area in the high-dose group compared with untreated control animals. A clear trend was noted in reducing the neointimal thickness and in increasing the residual lumen in the high-dose probucol group. This study suggests that antioxidant therapy inhibits restenosis.
Probucol slows the progression of atherosclerosis in the Watanabe heritable hyperlipemic rabbit.'3. 22 The mechanism has been attributed to the antioxidant prop- ing properties, Carew et a122 demonstrated that probucol works independently of these properties by comparing probucol-treated rabbits with a matched group of rabbits that received lovastatin to achieve a similar lipid profile. Total aortic lesion area was reduced by one half in the probucol-treated group with respect to the cholesterol-matched lovastatin-treated animals. In the subset of swine undergoing lipid analysis in our study, high-dose probucol did reduce total cholesterol, LDL, and HDL consistent with its lipid-lowering effect. 23 However, we believe that the lipid lowering is unlikely to explain the decrease in neointimal formation. In previous work using this model, we found that altering serum cholesterol by diet did not change the extent of neointimal growth. Additionally, lowering serum cholesterol by the administration of lovastatin to normolipemic or hyperlipemic swine did not decrease neointimal formation as compared with untreated animals. 24 Thus, we believe that probucol reduced neointimal formation in this model via its antioxidant properties.
The present study of coronary injury is different in several aspects from previous models that have demonstrated the benefits of probucol. 13, 22 First, this is the first coronary injury model to test antioxidants and thus may more accurately resemble human restenosis than the rabbit aortic model. Second, this is a normolipemic rather than a hyperlipemic model, thus further emphasizing that the effect of probucol probably is not due to lowering serum cholesterol. Third, the rapid prolifera- model is similar to human restenosis and therefore differs from the cholesterol-induced atherosclerosis model in which vascular lesion formation is considerably slower. Thus, we believe that the benefits of probucol first noted in the hyperlipemic atherosclerotic models can be extended to restenosis after balloon injury.
Recent data suggest that oxidative stress may directly stimulate smooth muscle cell proliferation. 16 A duality exists between vascular smooth muscle cell vasoconstrictors and growth factors: Notable among these are angiotensin II, a-thrombin, epidermal growth factor, and platelet-derived growth factor (PDGF).25-28 Active oxygen species are vasoconstrictors that also share growth-promoting properties.29,30 Rao and Berk16 showed that active oxygen species generated by xanthine/xanthine oxidase significantly stimulated DNA synthesis and c-myc mRNA levels in growth-arrested vascular smooth muscle cells. Administration of the scavenging enzymes superoxide dismutase and catalase demonstrated that hydrogen peroxide was primarily responsible for vascular smooth muscle cell growth. In related cell culture studies, uric acid, the end product of purine metabolism, also acted as a vascular smooth muscle cell growth factor.31 Xanthine oxidase, a major source for active oxygen species in vivo, is activated during ischemia and reperfusion.32 Thus, active oxygen species may be important stimuli for smooth muscle cell growth after arterial injury.
The generation of active oxygen species is ubiquitous in biological processes. Oxidative stress occurs in cells and tissues when the balance of free radical generation and oxidant defense mechanism is altered. The most likely source for free radical production in the porcine coronary model is activation of inflammatory cells. Leukocytic migration and accumulation at the site of vascular injury is well recognized.33,34 Activated neutrophils and macrophages release superoxide anion and hydrogen peroxide.35 In humans undergoing PTCA, release of elastase in the circulation indicates neutrophil activation.36 Additionally, Ueda et a137 demonstrated in a study of seven patients who died within 20 days after PTCA that abundant macrophages accumulate at the site of balloon angioplasty. Time course studies in our swine model demonstrate an extensive inflammatory reaction between day 1 and 7 after injury.38 In the rabbit model of vascular injury, intimal proliferation was reduced by corticosteroids, further supporting a role for inflammation in the response to vascular injury.39 Additionally, endothelial cells and smooth muscle cells can generate active oxygen species and thus could act in an autocrine fashion to stimulate intimal proliferation after injury.40 Implications of the Study Are active oxygen species important in restenosis? During the course of PTCA, active oxygen species are generated, as demonstrated by the fact that malondialdehyde, a product of lipid peroxidation, was transiently increased in the great cardiac vein in patients undergoing balloon angioplasty. 41 Serruys et al42 also found a transient rise in hypoxanthine and lactate production during balloon inflation suggesting activation of purine metabolism, a common pathway for production of active oxygen species. Perhaps more important than this transient oxidative stress is the subsequent vessel response to injury. Through local accumulation of leukocytes and Sh.0 . flat rnn macrophages at the site of vascular injury, dysfunction of the regenerated endothelium, and increase in smooth muscle cell mass, a persistent oxidative stress exists. Recent studies indicate that active oxygen species promote cellular growth and play a significant role in tumor promotion and degenerative diseases.43 Because restenosis is a consequence of activation and promotion of the growth program, oxidative stress probably is a contributing factor.
The findings in this study that the antioxidant drug probucol reduced the extent of intimal proliferation after balloon injury need further investigation. One major limitation was that inhibition of active oxygen species formation was not established during this study but was inferred based on the antioxidant properties of probucol. Determination of tissue injury by oxidative stress is complex and would be difficult using an in vivo model by currently available techniques. Currently, more potent antioxidants are being evaluated. If they are effective, a clinical trial of antioxidant therapy for restenosis will be appropriate.
